Published in EXS on January 01, 2010
Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease. Infect Immun (2011) 1.99
Subversion of cell signaling by pathogens. Cold Spring Harb Perspect Biol (2012) 1.08
Neurologic manifestations associated with an outbreak of typhoid fever, Malawi--Mozambique, 2009: an epidemiologic investigation. PLoS One (2012) 0.98
T346Hunter: a novel web-based tool for the prediction of type III, type IV and type VI secretion systems in bacterial genomes. PLoS One (2015) 0.94
An outer membrane channel protein of Mycobacterium tuberculosis with exotoxin activity. Proc Natl Acad Sci U S A (2014) 0.93
The Bacillus cereus Hbl and Nhe tripartite enterotoxin components assemble sequentially on the surface of target cells and are not interchangeable. PLoS One (2013) 0.85
The tuberculosis necrotizing toxin kills macrophages by hydrolyzing NAD. Nat Struct Mol Biol (2015) 0.84
Hijacking the endocytic machinery by microbial pathogens. Protoplasma (2010) 0.84
Engineered nanoparticles mimicking cell membranes for toxin neutralization. Adv Drug Deliv Rev (2015) 0.81
Obstructing toxin pathways by targeted pore blockage. Chem Rev (2012) 0.80
Toxin-Antitoxin Systems of Staphylococcus aureus. Toxins (Basel) (2016) 0.79
Bacterial effectors: learning on the fly. Adv Exp Med Biol (2012) 0.78
Biological Control beneath the Feet: A Review of Crop Protection against Insect Root Herbivores. Insects (2016) 0.75
Inhibiting Microbial Toxins Using Plant-Derived Compounds and Plant Extracts. Medicines (Basel) (2015) 0.75
Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature (1992) 8.39
Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci U S A (2006) 7.99
A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science (2006) 7.84
Biogenesis, architecture, and function of bacterial type IV secretion systems. Annu Rev Microbiol (2005) 6.16
Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine. Proc Natl Acad Sci U S A (1978) 6.01
Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev (2004) 5.80
Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J Bacteriol (2006) 4.75
The great escape: structure and function of the autotransporter proteins. Trends Microbiol (1998) 4.72
SV2 is the protein receptor for botulinum neurotoxin A. Science (2006) 4.51
Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol (2001) 4.48
Type VII secretion--mycobacteria show the way. Nat Rev Microbiol (2007) 4.45
Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis (2001) 4.06
The crystal structure of diphtheria toxin. Nature (1992) 3.80
EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol Microbiol (1997) 3.75
Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell (1991) 3.75
Structural insights into the assembly of the type III secretion needle complex. Science (2004) 3.49
Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect Immun (2005) 3.39
Signal sequences: more than just greasy peptides. Trends Cell Biol (1998) 3.18
Cholera toxin: interaction of subunits with ganglioside GM1. Science (1974) 3.11
Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun (2005) 3.06
Involvement of nicotinamide adenine dinucleotide in the action of cholera toxin in vitro. Proc Natl Acad Sci U S A (1975) 3.04
Hydrolysis of nicotinamide adenine dinucleotide by choleragen and its A protomer: possible role in the activation of adenylate cyclase. Proc Natl Acad Sci U S A (1976) 2.98
Structural basis of pore formation by the bacterial toxin pneumolysin. Cell (2005) 2.87
Substrate recognition strategy for botulinum neurotoxin serotype A. Nature (2004) 2.81
Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J Biol Chem (1993) 2.79
The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem (1999) 2.78
Type IV secretion systems and their effectors in bacterial pathogenesis. Curr Opin Microbiol (2006) 2.65
Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem (1994) 2.59
Two-partner secretion in Gram-negative bacteria: a thrifty, specific pathway for large virulence proteins. Mol Microbiol (2001) 2.58
PA63 channel of anthrax toxin: an extended beta-barrel. Biochemistry (2002) 2.57
Type II secretion: from structure to function. FEMS Microbiol Lett (2006) 2.51
The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family. Proc Natl Acad Sci U S A (1993) 2.50
Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc Natl Acad Sci U S A (1991) 2.49
The bacterial superantigen and superantigen-like proteins. Immunol Rev (2008) 2.44
Pore-forming protein toxins: from structure to function. Prog Biophys Mol Biol (2005) 2.36
Structure of a type IV secretion system core complex. Science (2009) 2.36
Legionella eukaryotic-like type IV substrates interfere with organelle trafficking. PLoS Pathog (2008) 2.33
Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. J Exp Med (2004) 2.32
Phylogeny of genes for secretion NTPases: identification of the widespread tadA subfamily and development of a diagnostic key for gene classification. Proc Natl Acad Sci U S A (2001) 2.28
Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science (1994) 2.24
VirB11 ATPases are dynamic hexameric assemblies: new insights into bacterial type IV secretion. EMBO J (2003) 2.23
Type I secretion in gram-negative bacteria. Biochim Biophys Acta (2004) 2.23
The MACPF/CDC family of pore-forming toxins. Cell Microbiol (2008) 2.15
The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med (2001) 2.12
Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J Biol Chem (1995) 2.06
Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1. J Immunol (2005) 2.01
Sequence homology and structural analysis of the clostridial neurotoxins. J Mol Biol (1999) 1.98
The structure of BtuB with bound colicin E3 R-domain implies a translocon. Nat Struct Biol (2003) 1.96
Requirement of pro-sequence for the production of active subtilisin E in Escherichia coli. J Biol Chem (1987) 1.94
Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J Biol Chem (1993) 1.93
The needle component of the type III secreton of Shigella regulates the activity of the secretion apparatus. J Biol Chem (2005) 1.92
Amino acid sequence of a heat-stable enterotoxin isolated from enterotoxigenic Escherichia coli strain 18D. FEBS Lett (1983) 1.85
Protein-translocating outer membrane porins of Gram-negative bacteria. Biochim Biophys Acta (2002) 1.83
Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J Cell Biol (2003) 1.81
A novel family of channel-forming, autotransporting, bacterial virulence factors. Mol Membr Biol (1998) 1.79
Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry (1996) 1.77
A conserved region within the Bordetella pertussis autotransporter BrkA is necessary for folding of its passenger domain. Mol Microbiol (2003) 1.74
IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes. Infect Immun (2005) 1.73
Role of ubiquitination in retro-translocation of cholera toxin and escape of cytosolic degradation. EMBO Rep (2002) 1.71
Type IV transporters of pathogenic bacteria. Curr Opin Microbiol (2003) 1.68
The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J Immunol (2005) 1.67
Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond. J Biol Chem (1994) 1.67
Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J Biol Chem (2004) 1.67
Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol Biol Cell (2008) 1.66
Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER. FEMS Microbiol Lett (2006) 1.65
The mechanism of pore formation by bacterial toxins. Curr Opin Struct Biol (2006) 1.61
Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes. Proc Natl Acad Sci U S A (2007) 1.59
A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4. J Mol Biol (2006) 1.59
Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol (2008) 1.59
The type III secretion system needle tip complex mediates host cell sensing and translocon insertion. Mol Microbiol (2007) 1.58
Essential structure for full enterotoxigenic activity of heat-stable enterotoxin produced by enterotoxigenic Escherichia coli. FEBS Lett (1985) 1.57
The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J Cell Biol (2003) 1.55
Autotransporter proteins, evolution and redefining protein secretion. Trends Microbiol (2000) 1.54
Structures of perfringolysin O suggest a pathway for activation of cholesterol-dependent cytolysins. J Mol Biol (2007) 1.54
Unique substrate recognition by botulinum neurotoxins serotypes A and E. J Biol Chem (2006) 1.54
Apical membrane chloride channels in a colonic cell line activated by secretory agonists. Am J Physiol (1988) 1.53
The domains of a cholesterol-dependent cytolysin undergo a major FRET-detected rearrangement during pore formation. Proc Natl Acad Sci U S A (2005) 1.52
Protein secretion and membrane insertion systems in gram-negative bacteria. J Membr Biol (2007) 1.51
Effects of Escherichia coli heat-stable enterotoxin STb on intestines of mice, rats, rabbits, and piglets. Infect Immun (1984) 1.49
Botulinum neurotoxins are zinc proteins. J Biol Chem (1992) 1.48
Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes. Infect Immun (1977) 1.48
The Haemophilus influenzae Hia adhesin is an autotransporter protein that remains uncleaved at the C terminus and fully cell associated. J Bacteriol (2000) 1.48
Type III export: new uses for an old pathway. Mol Microbiol (2001) 1.47
The Legionella pneumophila phosphatidylinositol-4 phosphate-binding type IV substrate SidC recruits endoplasmic reticulum vesicles to a replication-permissive vacuole. Cell Microbiol (2008) 1.46
Protein secretion in gram-negative bacteria: assembly of the three components of ABC protein-mediated exporters is ordered and promoted by substrate binding. EMBO J (1996) 1.44
Maturation and secretion of the non-typable Haemophilus influenzae HMW1 adhesin: roles of the N-terminal and C-terminal domains. Mol Microbiol (2000) 1.44
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42
Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa. J Biol Chem (1996) 1.41
Crystal structures of the OmpF porin: function in a colicin translocon. EMBO J (2008) 1.41
Clathrin-mediated endocytosis at synapses. Traffic (2007) 1.41
Subunit vaccine against the seven serotypes of botulism. Infect Immun (2007) 1.39
SecB functions as a cytosolic signal recognition factor for protein export in E. coli. Cell (1989) 1.38
Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J Biol Chem (2005) 1.37
Distinct steps in the penetration of adenylate cyclase toxin of Bordetella pertussis into sheep erythrocytes. Translocation of the toxin across the membrane. J Biol Chem (1992) 1.35
In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infect Immun (2002) 1.35
Membrane insertion: The strategies of toxins (review). Mol Membr Biol (1997) 1.32
Pathogenesis of acute bacterial diarrheal disorders. Annu Rev Med (1981) 1.32
Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. Structure (2002) 1.31
TCR recognition of peptide/MHC class II complexes and superantigens. Semin Immunol (2007) 1.30
Mechanism of substrate recognition by botulinum neurotoxin serotype A. J Biol Chem (2007) 1.30
Bacterial cytotoxins: targeting eukaryotic switches. Nat Rev Microbiol (2005) 1.98
An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists. Proc Natl Acad Sci U S A (2007) 1.85
Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors. J Comb Chem (2006) 1.79
Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins. J Biol Chem (2003) 1.60
Unique substrate recognition by botulinum neurotoxins serotypes A and E. J Biol Chem (2006) 1.54
The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability. Protein Expr Purif (2004) 1.45
Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry (2009) 1.41
Subunit vaccine against the seven serotypes of botulism. Infect Immun (2007) 1.39
Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins. Annu Rev Microbiol (2008) 1.35
In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infect Immun (2002) 1.35
Mechanism of substrate recognition by botulinum neurotoxin serotype A. J Biol Chem (2007) 1.30
Intracellular localization modulates targeting of ExoS, a type III cytotoxin, to eukaryotic signalling proteins. Mol Microbiol (2002) 1.17
Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS. J Biol Chem (2002) 1.16
Botulinum neurotoxin A protease: discovery of natural product exosite inhibitors. J Am Chem Soc (2010) 1.14
Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. Biochemistry (2007) 1.14
Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells. J Biol Chem (2003) 1.14
Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor. Proc Natl Acad Sci U S A (2011) 1.12
Gangliosides as high affinity receptors for tetanus neurotoxin. J Biol Chem (2009) 1.12
Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin. J Biol Chem (2008) 1.11
Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E. J Biol Chem (2007) 1.10
Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E. Infect Immun (2005) 1.10
Recombinant holotoxoid vaccine against botulism. Infect Immun (2007) 1.09
Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1. FEBS Lett (2010) 1.07
Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS. J Biol Chem (2004) 1.05
How bacterial ADP-ribosylating toxins recognize substrates. Nat Struct Mol Biol (2004) 1.04
Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate. Biochemistry (2006) 1.04
Uncoupling Crk signal transduction by Pseudomonas exoenzyme T. J Biol Chem (2005) 1.03
The ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells. Infect Immun (2010) 1.03
ADP-ribosylation and functional effects of Pseudomonas exoenzyme S on cellular RalA. Biochemistry (2002) 1.02
Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA . Biochemistry (2010) 1.01
Intracellular localization of type III-delivered Pseudomonas ExoS with endosome vesicles. J Biol Chem (2007) 1.01
Chirality holds the key for potent inhibition of the botulinum neurotoxin serotype a protease. Org Lett (2010) 0.99
Catalytic properties of botulinum neurotoxin subtypes A3 and A4. Biochemistry (2009) 0.99
A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells. Infect Immun (2005) 0.99
Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa. J Infect Dis (2002) 0.98
Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system. Infect Immun (2012) 0.97
Modulation of host cell endocytosis by the type III cytotoxin, Pseudomonas ExoS. Traffic (2008) 0.96
Molecular basis for tetanus toxin coreceptor interactions. Biochemistry (2008) 0.96
Vaccines against botulism. Curr Opin Microbiol (2012) 0.96
ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor. J Biol Chem (2004) 0.95
Engineering botulinum neurotoxin to extend therapeutic intervention. Proc Natl Acad Sci U S A (2009) 0.95
Botulinum neurotoxin B-host receptor recognition: it takes two receptors to tango. Nat Struct Mol Biol (2007) 0.93
Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25. J Biol Chem (2011) 0.91
Unique ganglioside recognition strategies for clostridial neurotoxins. J Biol Chem (2011) 0.90
Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidase. Bioorg Med Chem Lett (2009) 0.90
Structural analysis of botulinum neurotoxin type G receptor binding . Biochemistry (2010) 0.90
Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoS. Cell Microbiol (2007) 0.89
The pasteurella multocida toxin interacts with signalling pathways to perturb cell growth and differentiation. Int J Med Microbiol (2004) 0.89
Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons. J Biol Chem (2011) 0.89
Insights into the different catalytic activities of Clostridium neurotoxins. Biochemistry (2012) 0.89
Identification of a Natural Product Antagonist against the Botulinum Neurotoxin Light Chain Protease. ACS Med Chem Lett (2010) 0.89
Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. Cell Microbiol (2006) 0.89
Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry. J Biol Chem (2012) 0.88
Membrane localization contributes to the in vivo ADP-ribosylation of Ras by Pseudomonas aeruginosa ExoS. Infect Immun (2002) 0.88
Intracellular trafficking of Pseudomonas ExoS, a type III cytotoxin. Traffic (2007) 0.85
Association of botulinum neurotoxins with synaptic vesicle protein complexes. Toxicon (2009) 0.85
Synthetic substrate for application in both high and low throughput assays for botulinum neurotoxin B protease inhibitors. Bioorg Med Chem Lett (2009) 0.85
Adenylate cyclase activity of Pseudomonas aeruginosa ExoY can mediate bleb-niche formation in epithelial cells and contributes to virulence. Microb Pathog (2011) 0.84
The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic Cleft. ACS Med Chem Lett (2012) 0.84
The chaperone protein SmgGDS interacts with small GTPases entering the prenylation pathway by recognizing the last amino acid in the CAAX motif. J Biol Chem (2014) 0.83
Entry of a recombinant, full-length, atoxic tetanus neurotoxin into Neuro-2a cells. Infect Immun (2013) 0.83
General aspects and recent advances on bacterial protein toxins. Cold Spring Harb Perspect Med (2013) 0.83
Tumor biomarker glycoproteins in the seminal plasma of healthy human males are endogenous ligands for DC-SIGN. Mol Cell Proteomics (2011) 0.83
Subunit vaccine efficacy against Botulinum neurotoxin subtypes. Vaccine (2011) 0.81
Enhancing the protective immune response against botulism. Infect Immun (2013) 0.81
Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S. Biochemistry (2003) 0.81
Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis. J Clin Microbiol (2009) 0.80
Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cells. PLoS One (2013) 0.79
Host cell cytotoxicity and cytoskeleton disruption by CerADPr, an ADP-ribosyltransferase of Bacillus cereus G9241. Biochemistry (2013) 0.79
Expression and purification of two recombinant forms of the type-III cytotoxin, Pseudomonas aeruginosa ExoS. Protein Expr Purif (2002) 0.78
Unique ganglioside binding by botulinum neurotoxins C and D-SA. FEBS J (2011) 0.78
Exoenzyme S ADP-ribosylates Rab5 effector sites to uncouple intracellular trafficking. Infect Immun (2013) 0.78
Bacillus cereus Certhrax ADP-ribosylates vinculin to disrupt focal adhesion complexes and cell adhesion. J Biol Chem (2014) 0.76
Multiple domains of tetanus toxin direct entry into primary neurons. Traffic (2014) 0.75